Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril) (Q77769415)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 1999

Language	Label	Description	Also known as
English	Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)	scientific article published on 01 May 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

based on heuristic

inferred from title

Andrei C. Sposito

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Antonio de Padua Mansur

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

José Antonio F Ramires

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

O R Coelho

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J C Nicolau

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

83

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1497-9, A8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Responses to endothelium-dependent agonists in subcutaneous arteries excised from hypercholesterolaemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Association between plasma renin activity and metabolic cardiovascular risk factors in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Voltage-dependent Ca2+ channels in resistance arteries from spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

3-Hydroxy-3-methyl glutaryl coenzyme A reductase inhibition modulates vasopressin-stimulated Ca2+ responses in rat A10 vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Release of contracting autacoids by aortae of normal and atherosclerotic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900132-0

7 January 2021

Identifiers

10.1016/S0002-9149(99)00132-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10335771%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77769415&oldid=1725100912"